Jason Johnson
Overview
Jason Johnson is a partner in Crowell’s Health Care and Privacy & Cybersecurity Groups, where he draws on his experience as a former research scientist to advise clients on complex compliance, legal, regulatory, and transactional matters. He helps clients in the health care and life sciences industries navigate data privacy and cybersecurity issues under U.S. and European law. He also offers strategic insights to assist clients with product development, marketing, clinical research, and other core business initiatives.
Career & Education
- University of North Carolina at Chapel Hill, B.S.
- Franklin Pierce Law Center, J.D., magna cum laude
- New York
- U.S. District Court for the Eastern District of New York
- U.S. District Court for the Southern District of New York
- U.S. Patent and Trademark Office (USPTO)
- American Health Lawyers Association
- New York State Bar Association
- American Bar Association
Jason's Insights
Client Alert | 3 min read | 03.03.25
HHS Suggests It Will Provide Less Notice and Opportunity for Comment on Grant and Contract Rules
On February 28, the Department of Health and Human Services (HHS) announced that it was rescinding the Richardson Waiver, a policy in place since 1971 which said HHS would provide notice of proposed rulemaking in certain cases where it was not otherwise required to do so by law. This announcement signals a policy shift for the agency and suggests that where permitted by law, HHS will generally now issue rules relating to “agency management or personnel or to public property, loans, grants, benefits, or contracts” without providing notice and comment to stakeholders, and may otherwise find good cause to forego notice and comment procedures.
Client Alert | 3 min read | 02.27.25
House Committee Seeks Comment on New Comprehensive Data Privacy and Security Framework
Event | 02.25.25
Insights
Proposed Rule On Protecting Bulk Sensitive Data And Its Impact On Health Care
|12.06.24
Westlaw Today
How Health Cos. Can Brace For Tracking Tech Scrutiny
|08.24.23
Law360
Offensive and Defensive IP for AI in Health Care
|01.09.23
Reuters
Data Privacy and Artificial Intelligence in Health Care
|03.17.22
Reuters
"Best Practices in Recruiting for Health Equity: Designing a Successful Protocol for Recruitment," Clinical Trials Masterclass, New York, NY
|03.13.24
“Presentation of Attendee Clinical Trials With Focus on Recruiting,” Clinical Trials Masterclass, New York, NY
|03.13.24
Hospital Group Settles Data-Breach Case Of Naked Patient Photos For $65 Million
|09.17.24
The Wall Street Journal
HHS' health IT office makeover may tip the scales in historic funding battle
|08.06.24
FierceHealthcare
Hospital Worker Sentenced for HIPAA Crimes in ID Theft Scam
|06.07.23
Healthcare Info Security
Device Maker Zoll Facing 7 Lawsuits in Wake of Breach
|03.24.23
Healthcare Info Security
Congress Mulls Another Medical Device Cybersecurity Bill
|05.10.22
Healthcare Info Security
- |
01.31.25
Crowell Health Solution’s Trends in Transformation
- |
01.30.25
Crowell Health Solution’s Trends in Transformation
FDA Calls Out a Migraine TV Ad for Misleading Viewers
|10.17.24
Crowell Health Solution’s Trends in Transformation
HHS Reorganizes ONC and Bolsters AI Leadership
|08.16.24
Crowell Health Solution’s Trends in Transformation
FDA Publishes FAQs Around Its Recent Laboratory Developed Tests Final Rule
|08.12.24
Crowell Health Solution’s Trends in Transformation
FDA Issues Guidance on Using Electronic Health Records and Medical Claims Data in Clinical Studies
|08.01.24
Crowell Health Solution’s Trends in Transformation
New Federal Guidelines for Research Security Programs at Covered Institutions
|07.22.24
Crowell Health Solution’s Trends in Transformation
- |
07.16.24
Crowell Health Solution’s Trends in Transformation
Jason's Insights
Client Alert | 3 min read | 03.03.25
HHS Suggests It Will Provide Less Notice and Opportunity for Comment on Grant and Contract Rules
On February 28, the Department of Health and Human Services (HHS) announced that it was rescinding the Richardson Waiver, a policy in place since 1971 which said HHS would provide notice of proposed rulemaking in certain cases where it was not otherwise required to do so by law. This announcement signals a policy shift for the agency and suggests that where permitted by law, HHS will generally now issue rules relating to “agency management or personnel or to public property, loans, grants, benefits, or contracts” without providing notice and comment to stakeholders, and may otherwise find good cause to forego notice and comment procedures.
Client Alert | 3 min read | 02.27.25
House Committee Seeks Comment on New Comprehensive Data Privacy and Security Framework
Event | 02.25.25